Atlas Trials

Flu Vaccine Responses in the Setting of Melanoma Treatment

Clinical trial NCT03315975 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03315975
Sponsor
University of Pennsylvania
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Viral Vaccines
Start date
2017-10-20
Primary completion
2026-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.